The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6666845 7395835 I 6666845-2 20081122 20100318 20100331 EXP DSJ-2010-04496 DAIICHI SANKYO INC. 58 YR M N 20100326 CN BRAZIL

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6666845 1013442031 PS AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL 1 ORAL 20/5 MG (1 IN 1D), PER ORAL D D 22100

Indications of drugs used

Event ID DRUG SEQ INDI PT
6666845 1013442031 HYPERTENSION

Outcome of event

Event ID OUTC COD
6666845 HO

Reactions reported

Event ID PT
6666845 CEREBROVASCULAR ACCIDENT

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
6666845 CSM
6666845 FGN

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6666845 1013442031 20080101 20090101